Annual report pursuant to Section 13 and 15(d)

Research and Development (Details Narrative)

v3.24.1.u1
Research and Development (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Research and Development Arrangement, Contract to Perform for Others [Line Items]    
Research and development expenses $ 203,000 $ 486,000
Interest and financing expense 333,000 360,000
Accounts payable - licensing agreement 2,198,000 1,962,000
Revenues 0 0
A O T Prototys [Member]    
Research and Development Arrangement, Contract to Perform for Others [Line Items]    
Research and development expenses 14,000 298,000
Temple University License Agreements [Member]    
Research and Development Arrangement, Contract to Perform for Others [Line Items]    
Research and development expenses 188,000 188,000
Interest and financing expense 48,000 48,000
Accounts payable - licensing agreement $ 2,198,000 $ 1,962,000
Temple licensing agreement terms With regards to the unpaid fees to Temple, a total of $135,000 are deferred until such time the Company achieves a revenue milestone of $835,000 or upon termination of the licensing agreements and the remaining $2,063,000 are deemed past due. The Company is currently in discussions with Temple to settle or cure the past due balance.